Cortisol pharmacodynamics after methylprednisolone administration in young and elderly males

Journal of Clinical Pharmacology

Volumn 37, Issue 4, 1997, Pages 304-311

  Tornatore, Kathleen M ^a,c,e   Logue, Gerald ^b   Venuto, Rocco C ^a,c   Davis, Paul J ^d  

^a UNIVERSITY AT BUFFALO   (United States)

^b VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^c ERIE COUNTY MEDICAL CENTER   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE;

ADULT; AGE; AGED; AREA UNDER THE CURVE; ARTICLE; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CLEARANCE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL;

EID: 0030980564     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1997.tb04307.x     Document Type: Article

References (25)

1. Lamy P: Adverse drug effects. Clin Geriatr Med 1990; 6:293-307.
2. Pulliam CC, Steward RB: Adverse drug reactions in the elderly In, Penta F, Datiles U, Pickette L, Herndl C (eds.): Pharmacy Practice for the Geriatric Patient. Carrboro, NC: Health Sciences Consortium. 1985; 11-1-11-26.
3. Miller RR: Hospital admissions due to adverse drug reactions. Arch Int Med 1974; 134:219-223.
4. Thomas TPL: The complications of systemic corticosteroid therapy in the elderly. Gerontology 1984; 30:60-65.
5. Axelrod L: Side effects of glucocorticoid therapy. In, Schleimer RP, Claman HN, Oronsky A (eds.): Anti-inflammatory steroid action - basic clinical aspects. San Diego: Academic Press, 1989; 377-407.
6. Tyrrell JB, Baxter JD: Glucocorticoid therapy. In, Felig P, Baxter JD, Broadus AE, Frohman LA (eds.): Endocrinology and Metabolism. Toronto: McGraw-Hill, 1987; 788-817.
7. Tornatore KM, Biocevich DM, Reed KA, Tousley KL, Singh JP, Venuto RC: Methylprednisolone pharmacokinetics, cortisol response and adverse effects in black and white renal transplant recipients. Transplantation 1995; 59:729-736.
8. Mayersohn M: Special pharmacokinetic considerations in the elderly. In, Evans WE, Schentag JJ, Jusko WJ (eds.): Applied Pharmacokinetics - Principles of Therapeutic Drug Monitoring. Third Edition. Vancouver: Applied Therapeutics, 1992; 9-1-9-43.
9. Feely J, Coakley D: Altered pharmacodynamics in the elderly. Clin Geriatr Med 1990; 2:269-283.
10. Gurwitz JH, Avorn J: The ambiguous relation between aging and adverse drug reactions. Ann Intern Med 1991; 114:956-966.
11. 1983 Metropolitan Height and Weight Tables, Stat Bul Metropol Life Ins Co. 1983; 64(Jan-Jun);2.
12. Devine BJ: Gentamicin therapy. Drug Intell Clin Pharm 1974; 8:650-655.
13. Ebling WF, Szefler SJ, Jusko WJ: Analysis of cortisol, methylprednisolone and methylprednisolone hemisuccinate. J Chromatogr A 1984; 305:271-80.
14. Tornatore KM, Logue G, Venuto RC, Davis PJ: Pharmacokinetics of methylprednisolone in elderly and young healthy males. J Am Geriatr Soc 1994; 42:1118-1122.
15. Tornatore KM, Reed KA, Walshe JJ, Venuto RC: Cortisol pharmacodynamic response to long-term methylprednisolone in renal transplant recipients. Pharmacotherapy 1994; 14:111-118.
16. Rocci ML, Jusko WJ: LAGRAN program for area and moments in pharmacokinetic and analysis. Comput Methods Programs Biomed 1983; 16:203-213.
17. Glynn AM, Slaughter RL, Brass C, D'Ambrosio R, Jusko WJ: Effects of ketoconazole on methylprednisolone pharmacokinetics and cortisol secretion. Clin Pharmacol Ther 1986; 39:654-659.
18. Bolton S: Pharmaceutical statistics - practical and clinical applications. In, Swarbrick J, (ed): Pharmaceutical Statistics. Second Edition. New York: Marcel Dekker, 1990; 187-282.
19. Oxenkrug GF, Pomara N, McIntyre IM, Branconnier RJ, et al: Aging and cortisol resistance to suppression by dexamethasone: a positive correlation. Psych Res 1983; 10:125-130.
20. Sherman B, Sysham C, Pfohl B: Age-related changes in circadian rhythm of plasma cortisol in man. J Clin Endocrinol Metab 1985; 61:439-443.
21. Sapolsky R, Armanini M, Packman D, Tombaugh G: Stress and glucocorticoids in aging. Endocrin Metabolism Clin 1987; 16:965-980.
22. Reiss WG, Slaughter RL, Ludwig EA, Middleton E, Jusko WJ: Steroid dose sparing: pharmacodynamic responses to single versus divided doses of methylprednisolone in man. Clin Pharmacol Ther 1990; 85:1058-1066.
23. Kandrotas RJ, Slaughter RL, Brass C, Jusko WJ: Ketoconazole effects on methylprednisolone disposition and their joint suppression of endogenous cortisol. Clin Pharmacol Ther 1987; 42:465-470.
24. Stuck AE, Frey BM, Frey FJ: Kinetics of prednisolone and endogenous cortisol suppression in the elderly. Clin Pharmacol Ther 1988; 43:354-362.
25. Schimmer BP, Parker KL: Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In, Hardman JG, Limbird LE (eds.): Goodman and Gilman's The Pharmacologic Basis of Therapeutics. Ninth Edition. Toronto: McGraw-Hill, 1996; 1482-1485.